At EuroPCR in Paris, investigators of the controversial ORBITA trial presented two previously unreported benefits of percutaneous coronary intervention (PCI) for the study population.
Two hospitals in East Africa have announced participation in the American College of Cardiology’s CathPCI registry, which aims to assess treatments and outcomes related to cardiac catheterization and percutaneous coronary interventions (PCIs).
Percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) was associated with a 54 percent reduction in the composite endpoint of death, myocardial infarction and urgent revascularization when compared to medical therapy alone, according to five-year data from the FAME 2 trial.
New research from Florida State University suggests depression screening in patients with coronary artery disease (CAD) is especially crucial, because those individuals tend to have higher rates of morbidity and mortality.
May 22, 2018 | Practice Management
Pennsylvania-based Geisinger Health System plans to soon offer DNA sequencing to 1,000 patients, with the goal of providing the service to all three million of its patients.
Despite being performed in an older population with more cardiovascular comorbidities, transcatheter aortic valve replacement (TAVR) demonstrated similarly low rates of postoperative stroke and mortality compared with surgical aortic valve replacement (SAVR) in a study of patients with previous strokes.
Although survival after congenital heart surgery is improving, patients who receive procedures for even mild defects have long-term mortality rates at least three times higher than their counterparts in the general population, according to a U.S.-based registry study published in the Journal of the American College of Cardiology.
May 21, 2018 | Policy
In an opinion piece for USA Today, musician and actress Barbra Streisand noted inequalities for women in heart disease research and treatment—resulting in more deaths from cardiovascular disease.
Patients who suffer minor ischemic stroke or a transient ischemic attack (TIA) can lower the risk for a major stroke within 90 days by taking both clopidogrel and aspirin, according to a study published online May 16 in The New England Journal of Medicine.
May 21, 2018 | Lipids & Metabolic
Children who experienced partial readmission of new-onset type 1 diabetes had significantly lower total cholesterol levels and LDL cholesterol levels compared with non-remitters four to five years after diagnosis, according to a single-center study published May 16 in PLOS One.
Saphenous vein graft (SVG) lesions can be treated just as well with bare metal stents (BMS) as drug-eluting stents (DES), suggests a double-blind, randomized trial published May 11 in The Lancet.
May 21, 2018 | Healthcare Economics
Haider Warraich, MD, used the recently presented CABANA trial to launch into an opinion piece about the medical community’s eagerness to embrace new technologies and invasive procedures.
May 18, 2018 | Heart Failure
Researchers from the University of California Los Angeles (UCLA) have developed a new algorithm which better predicts pre- and post-heart transplant survival than existing methods.
One-fourth of transvenous implantable cardioverter defibrillator (ICD) leads has a mechanical complication within 10 years, according to an insurance database analysis published May 10 in the Journal of the American Heart Association.
Left radial access (LRA) for percutaneous coronary intervention (PCI) remains rare in the United Kingdom, according to a registry analysis—but it is associated with similar clinical outcomes as right radial access (RRA) and possibly a reduced risk of stroke.
Patients with stroke-related intracerebral hemorrhage (TICH-2) may benefit from receiving tranexamic acid (TXA), a drug treatment used to treat blood loss from trauma and bleeding after child birth, according to research presented May 16 at the European Stroke Conference in Sweden.
May 18, 2018 | Healthcare Economics
The National Institutes of Health (NIH) has halted enrollment in a $100 million, 10-year study of moderate alcohol intake and its effect on cardiovascular health amid concerns over conflicts of interest with the beverage industry.
May 17, 2018 | Heart Failure
A study published May 8 in the Journal of the American Heart Association suggests black and white patients with heart failure with reduced ejection fraction (HFrEF) derive similar benefit from beta-blockers, despite conflicting previous reports.
Wearable sensors and artificial intelligence (AI) could help predict the onset of cardiovascular disease by assessing an individual's changes in aerobic responses, according to new research published on Feb. 23 in the Journal of Applied Physiology.
Researchers at Imperial College London and the University of Edinburgh have developed machine learning software that detects small vessel disease (SVD)—which can ultimately cause stroke.
Acetaminophen after pediatric heart surgery was associated with an increasingly protective effect against acute kidney injury (AKI), according to an analysis of separate cohorts at two children’s hospitals.